Glucagon-Like Peptide-1 Receptor Agonists and Fragility Fracture Risk in Type 2 Diabetes

By afschroeder • July 25, 2026

Hamad CD, Wiener J, Golzar A, Kaur H, Henein C, Kittredge AP, Su G, Kaelber DC, Chan L, Yeaman MR, Adams JS, Bernthal NM, Sheppard WL. Glucagon-Like Peptide-1 Receptor Agonists and Fragility Fracture Risk in Type 2 Diabetes. JAMA Netw Open. 2026 Jul 1;9(7):e2625141. doi: 10.1001/jamanetworkopen.2026.25141. PMID: 42496972; PMCID: PMC13401206.

Tags: Harbor UCLA, Infectious Diseases, Publications

Multifactorial causes of severe persistent hypercalcemia in an immunosuppressed woman with chronic kidney disease

Nalluri K, Goodman EL, Pasupneti T, Nunez G, Wang EC. Multifactorial causes of severe persistent hypercalcemia in an immunosuppressed woman with chronic kidney disease. JCEM[...]

Effects of normobaric hypoxia and hyperthermia on ventilatory responses to high-intensity interval training bouts

Girardi M, Nicolò A, Marcora SM, Bazzucchi I, Felici F, Dickinson J, Sacchetti M. Effects of normobaric hypoxia and hyperthermia on ventilatory responses to high-intensity[...]

Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individuals with zero Agatston scores – Part I: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis and Framingham Heart Study

Naghavi M, Azimi A, Atlas K, Reeves AP, Zhang C, Mirjalili SR, Mozafarybazargany M, Jolfayi AG, Hashemi A, Atlas T, Wasserthal J, Vliegenthart R, Henschke[...]